Immunogenicity 14831
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
PIK3C2G
Transcript ID
uc010sic.2
HLA INFO
B*38:01
TCR INFO
No TCR info found!
Full length protein sequence (1264 aa)
MAEEY
1
RGCSI
6
QLVEV
11
PQSSN
16
TSLAS
21
FCNKV
26
KKIRE
31
RYHAA
36
DVNFN
41
SGKIW
46
STTTA
51
FPYQL
56
FSKTK
61
FNIHI
66
FIDNS
71
TQPLH
76
FMPCA
81
NYLVK
86
DLIAE
91
ILHFC
96
TNDQL
101
LPKDH
106
ILSVC
111
GSEEF
116
LQNDH
121
CLGSH
126
KMFQK
131
DKSVI
136
QLHLQ
141
KSREA
146
PGKLS
151
RKHEE
156
DHSQF
161
YLNQL
166
LEFMH
171
IWKVS
176
RQCLL
181
TLIRK
186
YDFHL
191
KYLLK
196
TQENV
201
YNIIE
206
EVKKI
211
CSVLG
216
CVETK
221
QITDA
226
VNELS
231
LILQR
236
KGENF
241
YQSSE
246
TSAKG
251
LIEKV
256
TTELS
261
TSIYQ
266
LINVY
271
CNSFY
276
ADFQP
281
VNVPR
286
CTSYL
291
NPGLP
296
SHLSF
301
TVYAA
306
HNIPE
311
TWVHS
316
YKAFS
321
FTCWL
326
TYAGK
331
KLCQV
336
RNYRN
341
IPDKK
346
LFFFL
351
VNWNE
356
TINFP
361
LEIKS
366
LPRES
371
MLTVK
376
LFGIA
381
CATNN
386
ANLLA
391
WTCLP
396
LFPKE
401
KSILG
406
SMLFS
411
MTLQS
416
EPPVE
421
MITPG
426
VWDVS
431
QPSPV
436
TLQID
441
FPATG
446
WEYMK
451
PDSEE
456
NRSNL
461
EEPLK
466
ECIKH
471
IARLS
476
QKQTP
481
LLLSE
486
EKKRY
491
LWFYR
496
FYCNN
501
ENCSL
506
PLVLG
511
SAPGW
516
DERTV
521
SEMHT
526
ILRRW
531
TFSQP
536
LEALG
541
LLTSS
546
FPDQE
551
IRKVA
556
VQQLD
561
NLLND
566
ELLEY
571
LPQLV
576
QAVKF
581
EWNLE
586
SPLVQ
591
LLLHR
596
SLQSI
601
QVAHR
606
LYWLL
611
KNAEN
616
EAYFK
621
SWYQK
626
LLAAL
631
QFCAG
636
KALND
641
EFSKE
646
QKLIK
651
ILGDI
656
GERVK
661
SASDH
666
QRQEV
671
LKKEI
676
GRLEE
681
FFQDV
686
NTCHL
691
PLNPA
696
LCIKG
701
IDHDA
706
CSYFT
711
SNALP
716
LKITF
721
INANP
726
MGKNI
731
SIIFK
736
AGDDL
741
RQDML
746
VLQLI
751
QVMDN
756
IWLQE
761
GLDMQ
766
MIIYR
771
CLSTG
776
KDQGL
781
VQMVP
786
DAVTL
791
AKIHR
796
HSGLI
801
GPLKE
806
NTIKK
811
WFSQH
816
NHLKA
821
DYEKA
826
LRNFF
831
YSCAG
836
WCVVT
841
FILGV
846
CDRHN
851
DNIML
856
TKSGH
861
MFHID
866
FGKFL
871
GHAQT
876
FGGIK
881
RDRAP
886
FIFTS
891
EMEYF
896
ITEGG
901
KNPQH
906
FQDFV
911
ELCCR
916
AYNII
921
RKHSQ
926
LLLNL
931
LEMML
936
YAGLP
941
ELSGI
946
QDLKY
951
VYNNL
956
RPQDT
961
DLEAT
966
SHFTK
971
KIKES
976
LECFP
981
VKLNN
986
LIHTL
991
AQMSA
996
ISPAK
1001
STSQT
1006
FPQES
1011
CLLST
1016
TRSIE
1021
RATIL
1026
GFSKK
1031
SSNLY
1036
LIQVT
1041
HSNNE
1046
TSLTE
1051
KSFEQ
1056
FSKLH
1061
SQLQK
1066
QFASL
1071
TLPEF
1076
PHWWH
1081
LPFTN
1086
SDHRR
1091
FRDLN
1096
HYMEQ
1101
ILNVS
1106
HEVTN
1111
SDCVL
1116
SFFLS
1121
EAVQQ
1126
TVEES
1131
SPVYL
1136
GEKFP
1141
DKKPK
1146
VQLVI
1151
SYEDV
1156
KLTIL
1161
VKHMK
1166
NIHLP
1171
DGSAP
1176
SAHVE
1181
FYLLP
1186
YPSEV
1191
RRRKT
1196
KSVPK
1201
CTDPT
1206
YNEIV
1211
VYDEV
1216
TELQG
1221
HVLML
1226
IVKSK
1231
TVFVG
1236
AINIR
1241
LCSVP
1246
LDKEK
1251
WYPLG
1256
NSII
1261
Mutation Information
DNA mutation:
None
Peptide Range:
510 ~ 534
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"LPLVLGSAPGWDERTVSEMHTILRR
||||||||||||.||||||||||||
Mutant:
LPLVLGSAPGWDKRTVSEMHTILRR"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) PIK3C2G
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay